ArticleFrontiers in immunology2025

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study.

Heinz Wiendl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.